Back

Biofilms and core pathogens shape the tumour microenvironment and immune phenotype in colorectal cancer

Kvich, L.; Fritz, B. G.; Zschach, H.; Terkelsen, T.; Raskov, H.; Hoest-Rasmussen, K.; Jakobsen, M. R.; Gheorghe, A. G.; Gogenur, I.; Bjarnsholt, T.

2023-10-20 cancer biology
10.1101/2023.10.20.563034 bioRxiv
Show abstract

ObjectiveGrowing evidence links bacterial dysbiosis with colorectal cancer (CRC) carcinogenesis, characterized by an increased presence of core pathogens such as Bacteroides fragilis and Fusobacterium nucleatum. Here, we characterized the in situ biogeography and transcriptional interactions between bacteria and the host in mucosal colon biopsies. DesignThe influence of CRC core pathogens and biofilms on the tumour microenvironment (TME) was investigated in biopsies from patients with and without CRC (paired normal tissue and healthy tissue biopsies) using fluorescence in situ hybridization and dual-RNA sequencing. ResultsTissue-invasive, mixed-species biofilms enriched for B. fragilis and F. nucleatum were observed in CRC tissue, especially in right-sided tumours. Fusobacterium spp. was associated with increased bacterial biomass and inflammatory response in CRC samples. CRC samples with high bacterial activity demonstrated increased expression of pro-inflammatory cytokines, defensins, matrix-metalloproteases, and immunomodulatory factors. In contrast, the gene expression profiles of CRC samples with low bacterial activity resembled healthy tissue samples. Moreover, immune cell profiling showed that B. fragilis and F. nucleatum modulated the TME and correlated with increased infiltration of neutrophils and CD4+ T-cells. Overall, bacterial activity was critical for the immune phenotype and correlated with the infiltration of several immune cell subtypes, including M2 macrophages and regulatory T-cells. ConclusionBiofilms and core pathogens shape the TME and immune phenotype in CRC. Our results support that Fusobacterium spp. may provide a future therapeutic target to reduce biofilms and the inflammatory response in the TME while highlighting the importance of widening the scope of bacterial pathogenesis in CRC beyond core pathogens.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
npj Biofilms and Microbiomes
56 papers in training set
Top 0.1%
34.4%
2
npj Precision Oncology
48 papers in training set
Top 0.1%
4.1%
3
Scientific Reports
3102 papers in training set
Top 40%
3.4%
4
Nature Communications
4913 papers in training set
Top 43%
2.8%
5
Gut Microbes
70 papers in training set
Top 0.4%
2.2%
6
International Journal of Cancer
42 papers in training set
Top 0.4%
2.2%
7
Gastroenterology
40 papers in training set
Top 0.8%
2.0%
50% of probability mass above
8
Cancers
200 papers in training set
Top 2%
2.0%
9
BMC Medicine
163 papers in training set
Top 3%
1.9%
10
Cell Reports Medicine
140 papers in training set
Top 3%
1.8%
11
PLOS ONE
4510 papers in training set
Top 52%
1.8%
12
Genome Medicine
154 papers in training set
Top 4%
1.8%
13
Cell Communication and Signaling
35 papers in training set
Top 0.4%
1.8%
14
Frontiers in Immunology
586 papers in training set
Top 4%
1.8%
15
Molecular Oncology
50 papers in training set
Top 0.4%
1.5%
16
mSystems
361 papers in training set
Top 5%
1.5%
17
PLOS Computational Biology
1633 papers in training set
Top 18%
1.4%
18
PeerJ
261 papers in training set
Top 10%
1.3%
19
Gut
36 papers in training set
Top 0.6%
1.3%
20
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.4%
1.3%
21
Frontiers in Oncology
95 papers in training set
Top 3%
1.2%
22
Microbiome
139 papers in training set
Top 2%
0.9%
23
British Journal of Cancer
42 papers in training set
Top 1%
0.9%
24
mSphere
281 papers in training set
Top 5%
0.9%
25
JCI Insight
241 papers in training set
Top 6%
0.8%
26
Evolutionary Applications
91 papers in training set
Top 1%
0.8%
27
Advanced Science
249 papers in training set
Top 18%
0.8%
28
Journal of Clinical Investigation
164 papers in training set
Top 6%
0.8%
29
Journal of Clinical Medicine
91 papers in training set
Top 6%
0.7%
30
eBioMedicine
130 papers in training set
Top 4%
0.7%